Prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine.

The influenza A non-structural protein 1 (NS1) is known for its ability to hinder the synthesis of type I interferon (IFN) during viral infection. Influenza viruses lacking NS1 (ΔNS1) are under clinical development as live attenuated human influenza virus vaccines and induce potent influenza virus-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rathnasinghe, Raveen, Salvatore, Mirella, Zheng, Hongyong, Jangra, Sonia, Kehrer, Thomas, Mena, Ignacio, Schotsaert, Michael, Muster, Thomas, Palese, Peter, García-Sastre, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366806/
https://www.ncbi.nlm.nih.gov/pubmed/34401874
http://dx.doi.org/10.21203/rs.3.rs-668116/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366806/
https://www.ncbi.nlm.nih.gov/pubmed/34401874
http://dx.doi.org/10.21203/rs.3.rs-668116/v1

Ejemplares similares